1.Lack of Rb2/p130 genetic alteration in Malaysian nasopharyngeal carcinoma.
Susan Ling Ling Hoe ; Ee Soo Lee ; Alan Soo Beng Khoo ; Suat-Cheng Peh
The Malaysian journal of pathology 2009;31(1):53-6
The retinoblastoma-related gene Rb2/p130 has been reported to be mutated in several malignancies such as lung cancer and Burkitt's lymphoma. Nasopharyngeal carcinoma (NPC) is a common cancer in Malaysia especially amongst the ethnic Chinese. We screened for Rb2/p130 gene (exons 19 to 21) mutations in 53 archival NPC samples via PCR-SSCP-direct sequencing approach. Only one sample had a base change which involved a serine to glycine substitution at codon 995 (S995G). We conclude that Rb2/p130 genetic alterations are infrequent in NPC and may not be essential for the pathogenesis of the disease.
Genetic
;
MALAYSIAN
;
Genes
;
Carcinoma
;
Malignant Neoplasms
2.Efficacy of a topical agent SS-cream in the treatment of premature ejaculation: preliminary clinical studies.
Zhong Cheng XIN ; Young Deuk CHOI ; Soo Hyung LEE ; Hyung Ki CHOI
Yonsei Medical Journal 1997;38(2):91-95
SS-cream is a topical agent for treating premature ejaculation (PE) which is made with extracts from 9 natural products. We evaluated the efficacy of SS-cream in the treatment of PE. An open pilot study was performed in 186 patients with PE. The mean ejaculatory latency from intromission to ejaculation was 1.5 minutes. Sixty-four of the 186 patients (34.4%) were combined with mild erectile dysfunction in whom penile rigidity was not sufficient to be satisfied in sexual activity. Patients were instructed to apply 0.1 gm. of SS-cream on the glans penis 1 hour before sexual contact and to wash out the cream before sexual intromission. Patients were asked to complete a report form including ejaculatory latency, the degree of satisfaction in the sexual lives of both themselves and their partners, and any adverse effects after each application. One hundred and sixty-six out of 186 patients (89.2%) reported they were satisfied with the application of the SS-cream and the mean ejaculatory latency was significantly prolonged to 10.89 +/- 5.60 minutes. The mean ejaculatory latency was 9.85 +/- 3.58 minutes in 52 out of 64 patients (81.2%) with mild erectile dysfunction. There was no significant difference in the changes of ejaculatory latencies between patients with pure PE and patients with mild erectile dysfunction. Twenty patients (10.8%) claimed to have no changes of ejaculatory latencies after the application of SS-cream. Adverse effects were noted in 11 patients (5.9%), which were mild local irritation symptoms in 7 patients, and delayed ejaculation of more than 30 minutes in 4 patients, the symptoms subsided spontaneously within 4 hours. These results indicate SS-cream is effective in the treatment of PE and also PE combined with mild erectile dysfunction with a few side effects. Further studies on the action mechanisms of SS-cream and a double blind placebo-controlled trial are needed.
Administration, Topical
;
Adult
;
Drugs, Chinese Herbal/administration & dosage*
;
Ejaculation/drug effects*
;
Human
;
Male
;
Middle Age
;
Penile Erection/drug effects
3.Optogenetic Rescue of Locomotor Dysfunction and Dopaminergic Degeneration Caused by Alpha-Synuclein and EKO Genes.
Cheng QI ; Scott VARGA ; Soo Jin OH ; C Justin LEE ; Daewoo LEE
Experimental Neurobiology 2017;26(2):97-103
α-Synuclein (α-Syn) is a small presynaptic protein and its mutant forms (e.g. A53T) are known to be directly associated with Parkinson's disease (PD). Pathophysiological mechanisms underlying α-Syn-mediated neurodegeneration in PD still remain to be explored. However, several studies strongly support that overexpression of mutant α-Syn causes reduced release of dopamine (DA) in the brain, and contributes to motor deficits in PD. Using a favorable genetic model Drosophila larva, we examined whether reduced DA release is enough to induce key PD symptoms (i.e. locomotion deficiency and DA neurodegeneration), mimicking a PD gene α-Syn. In order to reduce DA release, we expressed electrical knockout (EKO) gene in DA neurons, which is known to make neurons hypo-excitable. EKO led to a decrease in a DA neuronal marker signal (i.e., TH – tyrosine hydroxylase) and locomotion deficits in Drosophila larva. In contrast, acute and prolonged exposure to blue light (BL, 470 nm) was sufficient to activate channelrhodopsin 2 (ChR2) and rescue PD symptoms caused by both α-Syn and EKO. We believe this is for the first time to confirm that locomotion defects by a genetic PD factor such as α-Syn can be rescued by increasing DA neuronal excitability with an optogenetic approach. Our findings strongly support that PD is a failure of DA synaptic transmission, which can be rescued by optogenetic activation of ChR2.
alpha-Synuclein*
;
Brain
;
Dopamine
;
Dopaminergic Neurons
;
Drosophila
;
Drosophila melanogaster
;
Larva
;
Locomotion
;
Models, Genetic
;
Neurons
;
Optogenetics*
;
Parkinson Disease
;
Synaptic Transmission
;
Tyrosine
4.The Relationships between Physical Activity and Immanent Fall Risk Factors in the Elderly.
On LEE ; Hyun Suk NAM ; Sung A KONG ; Jae Woo KIM ; Cheng Zhu KIM ; Hyun Ju KANG ; Yeon Soo KIM
The Korean Journal of Sports Medicine 2010;28(2):95-102
The purpose of this study was to investigate relationships between physical activity and immanent fall risk factors in the elderly. The subjects were 138 (male: n=51; female: n=87) elderly who have no restriction in daily physical activity. Physical activity was measured over consecutive seven days by accelerometer. Immanent fall risk factors (Berg Balance Scale [BBS], Activities-specific Balance Confidence [ABC], and gait-related fitness) were measured. There are significant correlations between physical activity and BBS (male r=0.46, female r=0.36), gait-related fitness (male r=0.44, female r=0.43). And there are significant correlations between physical activity and ABC in female (r=0.38). Through this study, it is assumed that physical activity has correlation with immanent fall risk factors. Also, physical activity has correlation with gate-related fitness in the elderly.
Aged
;
Female
;
Humans
;
Motor Activity
;
Risk Factors
5.Percutaneous Balloon Valvuloplasty of Pulmonary Valvular Stenosis in Adult.
Jae Hyung PARK ; Byoung Hee OH ; Yong Soo YUN ; Man Cheng HAN ; Young Bae PARK ; Yun Shik CHOI ; Jeong Don SEO ; Young Woo LEE
Korean Circulation Journal 1987;17(1):25-32
Percutaneous balloon valvuloplasty (PBV) was done in 7 adults of pulmonary valvular stenosis, which was diagnosed with catheterization and cine-angiography of rigtht heart, in Seoul National University Hospital from Jan. 1986 to Dec. 1986. The results were as follows : 1) Among the seven cases six were male and the range of age was from 19 to 40 years. Atrial septal defects associated in 2 cases were not significant clinically. 2) The peak systolic gradient from right ventricle to pulmonary artery before the procedure was below 50 mmhg in 1 cases, 50 to 100 mmHg in 1 case, and above 100 mmHg in 5 cases. 3) Before PBV the mean systolic pressure of right ventricle was 121+/-42 mmHg and the peak systolic gradient was 106+/-41 mmHg. After PBV those were 58+/-30 mmHg and 40+/-31 mmHg, revealing significant improvement. 4) Balloon catheter (Medi-tech, 9F) was used in all cases. single balloon of 20 mm outer diameter was applied in 2 cases and double balloons of various sizes were applied in 5 cases in which single balloon showed inadequate dilatation. It is suggested that percutaneous balloon valvuloplasty is safe and effective alternative to surgical valvotomy of pulmonary valvular stenosis in adults.
Adult*
;
Balloon Valvuloplasty*
;
Blood Pressure
;
Catheterization
;
Catheters
;
Constriction, Pathologic*
;
Dilatation
;
Heart
;
Heart Septal Defects, Atrial
;
Heart Ventricles
;
Humans
;
Male
;
Pulmonary Artery
;
Seoul
6.Effect of Ischemic Preconditioning for Preventing Ischemic Injury of the Spinal Cord.
Jong Myeon HONG ; Che Cheng RI ; Woo Ik SONG ; Jang Soo HONG ; Seung Woon LIM ; Geon Kook LEE ; Seung Pyung LIM
The Korean Journal of Thoracic and Cardiovascular Surgery 2001;34(11):823-830
BACKGROUND: Paraplegia is a serious complication of thoracic or thoracoabdominal aortic operations, which is related to ischemic injury of the spinal cord induced by low perfusion pressure during cross clamping of the aorta. Ischemic preconditioning of heart or brain with reversible sublethal ischemic injury induces resistance to subsequent lethal ischemia. The aim of this study is to investigate whether ischemic tolerance could be induced by the preconditioning of the spinal cord using swine model. MATERIAL AND METHOD: The animals were randomly assigned to three groups: sham group(n=3), control group(n=6) and preconditioning group(n=8). In the sham group, we performed the left thoracotomy only without any ischemic injury. In the preconditioning group, the swine received reversible spinal cord ischemic injury by aortic clamping for 20minutes, whereas control group had no previous aortic cross- clamping. Forty-eight hours later, the aorta was clamped for 30 minutes in both groups. Neurological examination was done 24hours later, then the animals were euthanized for histopathology and malonedialdehyde(MDA) spectrophotometry assay of the spinal cord. RESULT: Statistically significant difference in neurological outcome was observed between the control and preconditioning groups at 24hours after ischemic injury. The incidence of paraplegia and severe paresis was 100% in the control group, and 62.5% in the preconditing group(p=0.028). There was no statistically significant difference in histopathology and MDA assay of the ischemic spinal cord between these two groups with borderline statistical difference in MDA assay(p=0.0745). CONCLUSION: In the present swine study, ischemic preconditioning could induce tolerance against 30 minute ischemic insult of the spinal cord, although the animals did not completely recover(stand-up or walk). We expect that combining this preconditioning with other currently existing protection methods might lead to a synergistic effect, which warrants further investigation.
Animals
;
Aorta
;
Brain
;
Constriction
;
Heart
;
Incidence
;
Ischemia
;
Ischemic Preconditioning*
;
Neurologic Examination
;
Paraplegia
;
Paresis
;
Perfusion
;
Spectrophotometry
;
Spinal Cord*
;
Swine
;
Thoracotomy
7.Paediatric emergency department attendances during COVID-19 and SARS in Singapore.
Ronald M R TAN ; Sashikumar GANAPATHY ; Arif TYEBALLY ; Khai Pin LEE ; Shu Ling CHONG ; Jenifer S L SOO ; Koh Cheng THOON ; Yoke Hwee CHAN ; Kee Chong NG
Annals of the Academy of Medicine, Singapore 2021;50(2):126-134
INTRODUCTION:
We evaluated the impact of public health measures on paediatric emergency department attendances during the COVID-19 and severe acute respiratory syndrome (SARS) outbreaks in Singapore.
METHODS:
Between 1 January 2020 and 31 July 2020, we retrospectively reviewed paediatric emergency department attendances and admissions in a tertiary paediatric hospital in Singapore before and after a national lockdown to combat the spread of COVID-19 in Singapore. Hospital attendances and admissions were compared with data from a corresponding period in 2019 (1 January 2019 to 31 July 2019), as well as during and after the SARS outbreak (1 January 2003 to 31 December 2004).
RESULTS:
Compared with a corresponding non-outbreak period, emergency department attendances decreased in line with nationwide public health measures during the COVID-19 and SARS outbreaks (2020 and 2003 respectively), before increasing gradually following lifting of restrictions, albeit not to recorded levels before these outbreaks. During the COVID-19 outbreak, mean daily attendances decreased by 40%, from 458 per day in January-July 2019, to 274 per day in January-July 2020. The absolute number of hospital inpatient admissions decreased by 37% from January-July 2019 (19,629) to January-July 2020 (12,304). The proportion of emergency department attendances requiring admission remained similar: 20% in January-July 2019 and 21% in January-July 2020.
CONCLUSION
Nationwide public health measures in Singapore have had an impact on paediatric emergency department attendances and hospital inpatient admissions. Data from this study could inform planning and resource allocation for emergency departments in Singapore and internationally.
Adolescent
;
COVID-19/prevention & control*
;
Child
;
Child, Preschool
;
Disease Outbreaks
;
Emergency Service, Hospital/trends*
;
Facilities and Services Utilization/trends*
;
Female
;
Health Policy
;
Humans
;
Infant
;
Infant, Newborn
;
Male
;
Patient Acceptance of Health Care/statistics & numerical data*
;
Patient Admission/trends*
;
Pediatrics
;
Retrospective Studies
;
Severe Acute Respiratory Syndrome/epidemiology*
;
Singapore/epidemiology*
8.Impact of adjuvant treatment on survival in patients with 2023 FIGO stage IIC endometrial cancer: a retrospective analysis from two tertiary centers in Korea and Taiwan
Yoo-Young LEE ; Yen-Ling LAI ; Myeong-Seon KIM ; Koping CHANG ; Hyun-Soo KIM ; Wen-Fang CHENG ; Yu-Li CHEN
Journal of Gynecologic Oncology 2024;35(3):e33-
Objective:
In early-stage endometrial cancer, aggressive histologic types (grade 3 endometrioid, serous, clear cell, carcinosarcomas, undifferentiated, mixed, and other unusual types) are associated with an increased risk of distant metastases and worse survival. However, the optimal adjuvant treatment for these patients remains controversial. The present study investigated the outcomes of different adjuvant treatments in patients with 2023 FIGO stage IIC endometrial cancer.
Methods:
We retrospectively identified patients with 2023 FIGO stage IIC endometrial cancer who underwent surgery followed by either adjuvant treatment or observation from 2000 to 2020 at two tertiary centers in Korea and Taiwan. Recurrence-free survival (RFS) and overall survival (OS) were evaluated using Kaplan-Meier estimates and Cox proportional-hazards models. We also analyzed recurrence patterns after different adjuvant treatments.
Results:
A total of 272 patients were identified; 204 received adjuvant treatment postoperatively, whereas 68 only underwent observation. Adjuvant treatment was not associated with improved RFS or OS. Non-endometrioid histologic types (p=0.003) and presence of lymphovascular space invasion (LVSI, p=0.002) were associated with worse RFS, whereas only non-endometrioid histologic types impacted OS (p=0.004). In subgroup analyses, adjuvant treatment improved OS in patients with LVSI (p=0.020) and in patients with both LVSI and grade 3 endometrioid histologic type (p=0.007). We found no difference in locoregional and distant recurrence between patients undergoing adjuvant treatment or observation.
Conclusion
In this study, the addition of adjuvant treatment was associated with an OS benefit for patients with LVSI, especially those with grade 3 endometrioid tumors.
9.Impact of adjuvant treatment on survival in patients with 2023 FIGO stage IIC endometrial cancer: a retrospective analysis from two tertiary centers in Korea and Taiwan
Yoo-Young LEE ; Yen-Ling LAI ; Myeong-Seon KIM ; Koping CHANG ; Hyun-Soo KIM ; Wen-Fang CHENG ; Yu-Li CHEN
Journal of Gynecologic Oncology 2024;35(3):e33-
Objective:
In early-stage endometrial cancer, aggressive histologic types (grade 3 endometrioid, serous, clear cell, carcinosarcomas, undifferentiated, mixed, and other unusual types) are associated with an increased risk of distant metastases and worse survival. However, the optimal adjuvant treatment for these patients remains controversial. The present study investigated the outcomes of different adjuvant treatments in patients with 2023 FIGO stage IIC endometrial cancer.
Methods:
We retrospectively identified patients with 2023 FIGO stage IIC endometrial cancer who underwent surgery followed by either adjuvant treatment or observation from 2000 to 2020 at two tertiary centers in Korea and Taiwan. Recurrence-free survival (RFS) and overall survival (OS) were evaluated using Kaplan-Meier estimates and Cox proportional-hazards models. We also analyzed recurrence patterns after different adjuvant treatments.
Results:
A total of 272 patients were identified; 204 received adjuvant treatment postoperatively, whereas 68 only underwent observation. Adjuvant treatment was not associated with improved RFS or OS. Non-endometrioid histologic types (p=0.003) and presence of lymphovascular space invasion (LVSI, p=0.002) were associated with worse RFS, whereas only non-endometrioid histologic types impacted OS (p=0.004). In subgroup analyses, adjuvant treatment improved OS in patients with LVSI (p=0.020) and in patients with both LVSI and grade 3 endometrioid histologic type (p=0.007). We found no difference in locoregional and distant recurrence between patients undergoing adjuvant treatment or observation.
Conclusion
In this study, the addition of adjuvant treatment was associated with an OS benefit for patients with LVSI, especially those with grade 3 endometrioid tumors.
10.Impact of adjuvant treatment on survival in patients with 2023 FIGO stage IIC endometrial cancer: a retrospective analysis from two tertiary centers in Korea and Taiwan
Yoo-Young LEE ; Yen-Ling LAI ; Myeong-Seon KIM ; Koping CHANG ; Hyun-Soo KIM ; Wen-Fang CHENG ; Yu-Li CHEN
Journal of Gynecologic Oncology 2024;35(3):e33-
Objective:
In early-stage endometrial cancer, aggressive histologic types (grade 3 endometrioid, serous, clear cell, carcinosarcomas, undifferentiated, mixed, and other unusual types) are associated with an increased risk of distant metastases and worse survival. However, the optimal adjuvant treatment for these patients remains controversial. The present study investigated the outcomes of different adjuvant treatments in patients with 2023 FIGO stage IIC endometrial cancer.
Methods:
We retrospectively identified patients with 2023 FIGO stage IIC endometrial cancer who underwent surgery followed by either adjuvant treatment or observation from 2000 to 2020 at two tertiary centers in Korea and Taiwan. Recurrence-free survival (RFS) and overall survival (OS) were evaluated using Kaplan-Meier estimates and Cox proportional-hazards models. We also analyzed recurrence patterns after different adjuvant treatments.
Results:
A total of 272 patients were identified; 204 received adjuvant treatment postoperatively, whereas 68 only underwent observation. Adjuvant treatment was not associated with improved RFS or OS. Non-endometrioid histologic types (p=0.003) and presence of lymphovascular space invasion (LVSI, p=0.002) were associated with worse RFS, whereas only non-endometrioid histologic types impacted OS (p=0.004). In subgroup analyses, adjuvant treatment improved OS in patients with LVSI (p=0.020) and in patients with both LVSI and grade 3 endometrioid histologic type (p=0.007). We found no difference in locoregional and distant recurrence between patients undergoing adjuvant treatment or observation.
Conclusion
In this study, the addition of adjuvant treatment was associated with an OS benefit for patients with LVSI, especially those with grade 3 endometrioid tumors.